Biopharmaceutical leader in the development of treatments for rare diseases
H.R.1425: Patient Protection and Affordable Care Enhancement Act. CMS IPPS rule as it relates to the NTAP program.
HCR - Health Issues MMM - Medicare/Medicaid
2 - HOUSE OF REPRESENTATIVES 2 - HOUSE OF REPRESENTATIVES
W STRATEGIES, LLC
1455 Pennsylvania Avenue, NW, Suite 400, Washington, DC, 20004, US
DARREN WILLCOX DARREN WILLCOX